🇺🇸 FDA

Company profile · Sponsor

Zenas

Zenas BioPharma

ZBIO · NYSE biotech WALTHAM, MA, USA
Pipeline
13
Drugs
0
Patents
0

Quick answer

Zenas (ZBIO) is a biotech company. headquartered in WALTHAM, MA, USA. listed on NYSE. NovaPharmaNews links 13 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker ZBIO
Exchange NYSE
Company type biotech
Headquarters WALTHAM, MA, USA
SEC CIK 0001953926

Pipeline (13)

Search pipeline →

  1. Obexelimab

    Zenas

    IgG4 Related Disease

    phase 3 small molecule active

    1 trial

  2. Obexelimab

    Zenas

    Warm Autoimmune Hemolytic Anemia

    phase 3 small molecule active

    1 trial

  3. Orelabrutinib

    Zenas

    Secondary Progressive Multiple Sclerosis

    phase 3 small molecule active

    1 trial

  4. Orelabrutinib

    Zenas

    Multiple Sclerosis (MS) Primary Progressive

    phase 3 small molecule active

    1 trial

  5. Orelabrutinib, Placebo tablets match with that of orelabrutinib (ICP-022) tablets in appearance, shape, size, and weight.

    Zenas

    Primary Progressive Multiple Sclerosis (PPMS)

    phase 3 small molecule active

    1 trial

  6. Obexelimab

    Zenas

    Relapsing Multiple Sclerosis

    phase 2 small molecule active

    1 trial

  7. Obexelimab

    Zenas

    Systemic Lupus Erythematosus

    phase 2 small molecule active

    1 trial

  8. Obexelimab, Placebo sterile solution for SC injection, PREDNISOLONE

    Zenas

    Systemic Lupus Erythematosus

    phase 2 small molecule active

    1 trial

  9. Placebo sterile solution for SC injection, Obexelimab

    Zenas

    RELAPSING MULTIPLE SCLEROSIS

    phase 2 small molecule active

    1 trial

  10. ZB001 for injection

    Zenas

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. ZB001 for injection

    Zenas

    Thyroid Eye Disease

    phase 1 small molecule completed

    1 trial

  12. ZB002

    Zenas

    Healthy Volunteers

    phase 1 small molecule active

    1 trial

  13. ZB004

    Zenas

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is Zenas?

Zenas (ZBIO) is a biotech company. headquartered in WALTHAM, MA, USA. listed on NYSE. NovaPharmaNews links 13 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Zenas sponsor?

We track 13 ClinicalTrials.gov-linked programs for Zenas, including Obexelimab and 12 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Zenas company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.